93 related articles for article (PubMed ID: 31254321)
1. Rational Adaptation of L3MBTL1 Inhibitors to Create Small-Molecule Cbx7 Antagonists.
Simhadri C; Daze KD; Douglas SF; Milosevich N; Monjas L; Dev A; Brown TM; Hirsch AKH; Wulff JE; Hof F
ChemMedChem; 2019 Aug; 14(15):1444-1456. PubMed ID: 31254321
[TBL] [Abstract][Full Text] [Related]
2. Chromodomain antagonists that target the polycomb-group methyllysine reader protein chromobox homolog 7 (CBX7).
Simhadri C; Daze KD; Douglas SF; Quon TT; Dev A; Gignac MC; Peng F; Heller M; Boulanger MJ; Wulff JE; Hof F
J Med Chem; 2014 Apr; 57(7):2874-83. PubMed ID: 24625057
[TBL] [Abstract][Full Text] [Related]
3. Small-molecule modulators of methyl-lysine binding for the CBX7 chromodomain.
Ren C; Morohashi K; Plotnikov AN; Jakoncic J; Smith SG; Li J; Zeng L; Rodriguez Y; Stojanoff V; Walsh M; Zhou MM
Chem Biol; 2015 Feb; 22(2):161-8. PubMed ID: 25660273
[TBL] [Abstract][Full Text] [Related]
4. Aza-amino acid scanning of chromobox homolog 7 (CBX7) ligands.
Traoré M; Gignac M; Doan ND; Hof F; Lubell WD
J Pept Sci; 2017 Apr; 23(4):266-271. PubMed ID: 28220557
[TBL] [Abstract][Full Text] [Related]
5. The molecular selectivity of UNC3866 inhibitor for Polycomb CBX7 protein from molecular dynamics simulation.
Liu H; Li Z; Li L
Comput Biol Chem; 2018 Jun; 74():339-346. PubMed ID: 29723807
[TBL] [Abstract][Full Text] [Related]
6. Optimization of Ligands Using Focused DNA-Encoded Libraries To Develop a Selective, Cell-Permeable CBX8 Chromodomain Inhibitor.
Wang S; Denton KE; Hobbs KF; Weaver T; McFarlane JMB; Connelly KE; Gignac MC; Milosevich N; Hof F; Paci I; Musselman CA; Dykhuizen EC; Krusemark CJ
ACS Chem Biol; 2020 Jan; 15(1):112-131. PubMed ID: 31755685
[TBL] [Abstract][Full Text] [Related]
7. Chromobox protein homologue 7 protein, with decreased expression in human carcinomas, positively regulates E-cadherin expression by interacting with the histone deacetylase 2 protein.
Federico A; Pallante P; Bianco M; Ferraro A; Esposito F; Monti M; Cozzolino M; Keller S; Fedele M; Leone V; Troncone G; Chiariotti L; Pucci P; Fusco A
Cancer Res; 2009 Sep; 69(17):7079-87. PubMed ID: 19706751
[TBL] [Abstract][Full Text] [Related]
8. The complex CBX7-PRMT1 has a critical role in regulating E-cadherin gene expression and cell migration.
Federico A; Sepe R; Cozzolino F; Piccolo C; Iannone C; Iacobucci I; Pucci P; Monti M; Fusco A
Biochim Biophys Acta Gene Regul Mech; 2019 Apr; 1862(4):509-521. PubMed ID: 30826432
[TBL] [Abstract][Full Text] [Related]
9. Synthetic trimethyllysine receptors that bind histone 3, trimethyllysine 27 (H3K27me3) and disrupt its interaction with the epigenetic reader protein CBX7.
Tabet S; Douglas SF; Daze KD; Garnett GA; Allen KJ; Abrioux EM; Quon TT; Wulff JE; Hof F
Bioorg Med Chem; 2013 Nov; 21(22):7004-10. PubMed ID: 24100156
[TBL] [Abstract][Full Text] [Related]
10. CBX7 inhibits breast tumorigenicity through DKK-1-mediated suppression of the Wnt/β-catenin pathway.
Kim HY; Park JH; Won HY; Lee JY; Kong G
FASEB J; 2015 Jan; 29(1):300-13. PubMed ID: 25351982
[TBL] [Abstract][Full Text] [Related]
11. Polycomb CBX7 directly controls trimethylation of histone H3 at lysine 9 at the p16 locus.
Li Q; Wang X; Lu Z; Zhang B; Guan Z; Liu Z; Zhong Q; Gu L; Zhou J; Zhu B; Ji J; Deng D
PLoS One; 2010 Oct; 5(10):e13732. PubMed ID: 21060834
[TBL] [Abstract][Full Text] [Related]
12. Structure-Activity Relationships of Cbx7 Inhibitors, Including Selectivity Studies against Other Cbx Proteins.
Simhadri C; Gignac MC; Anderson CJ; Milosevich N; Dheri A; Prashar N; Flemmer RT; Dev A; Henderson TG; Douglas SF; Wulff JE; Hof F
ACS Omega; 2016 Oct; 1(4):541-551. PubMed ID: 30023485
[TBL] [Abstract][Full Text] [Related]
13. Discovery and Characterization of a Cellular Potent Positive Allosteric Modulator of the Polycomb Repressive Complex 1 Chromodomain, CBX7.
Lamb KN; Bsteh D; Dishman SN; Moussa HF; Fan H; Stuckey JI; Norris JL; Cholensky SH; Li D; Wang J; Sagum C; Stanton BZ; Bedford MT; Pearce KH; Kenakin TP; Kireev DB; Wang GG; James LI; Bell O; Frye SV
Cell Chem Biol; 2019 Oct; 26(10):1365-1379.e22. PubMed ID: 31422906
[TBL] [Abstract][Full Text] [Related]
14. Structure-Guided Discovery of Selective Antagonists for the Chromodomain of Polycomb Repressive Protein CBX7.
Ren C; Smith SG; Yap K; Li S; Li J; Mezei M; Rodriguez Y; Vincek A; Aguilo F; Walsh MJ; Zhou MM
ACS Med Chem Lett; 2016 Jun; 7(6):601-5. PubMed ID: 27326334
[TBL] [Abstract][Full Text] [Related]
15. Structure-Activity Relationships and Kinetic Studies of Peptidic Antagonists of CBX Chromodomains.
Stuckey JI; Simpson C; Norris-Drouin JL; Cholensky SH; Lee J; Pasca R; Cheng N; Dickson BM; Pearce KH; Frye SV; James LI
J Med Chem; 2016 Oct; 59(19):8913-8923. PubMed ID: 27571219
[TBL] [Abstract][Full Text] [Related]
16. Live-cell single-molecule tracking reveals co-recognition of H3K27me3 and DNA targets polycomb Cbx7-PRC1 to chromatin.
Zhen CY; Tatavosian R; Huynh TN; Duc HN; Das R; Kokotovic M; Grimm JB; Lavis LD; Lee J; Mejia FJ; Li Y; Yao T; Ren X
Elife; 2016 Oct; 5():. PubMed ID: 27723458
[TBL] [Abstract][Full Text] [Related]
17. Denaturing CLIP, dCLIP, Pipeline Identifies Discrete RNA Footprints on Chromatin-Associated Proteins and Reveals that CBX7 Targets 3' UTRs to Regulate mRNA Expression.
Rosenberg M; Blum R; Kesner B; Maier VK; Szanto A; Lee JT
Cell Syst; 2017 Oct; 5(4):368-385.e15. PubMed ID: 29073373
[TBL] [Abstract][Full Text] [Related]
18. Polycomb chromobox (Cbx) 7 modulates activation-induced CD4+ T cell apoptosis.
Li J; Li Y; Cao Y; Yuan M; Gao Z; Guo X; Zhu F; Wang Y; Xu J
Arch Biochem Biophys; 2014 Dec; 564():184-8. PubMed ID: 25449062
[TBL] [Abstract][Full Text] [Related]
19. [Downregulation of chromobox protein homolog 7 expression in multiple human cancer tissues].
Guan ZP; Gu LK; Xing BC; Ji JF; Gu J; Deng DJ
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jul; 45(7):597-600. PubMed ID: 22041561
[TBL] [Abstract][Full Text] [Related]
20. CBX7 suppresses cell proliferation, migration, and invasion through the inhibition of PTEN/Akt signaling in pancreatic cancer.
Ni S; Wang H; Zhu X; Wan C; Xu J; Lu C; Xiao L; He J; Jiang C; Wang W; He Z
Oncotarget; 2017 Jan; 8(5):8010-8021. PubMed ID: 28030829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
